Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments

David Della Morte, Fiorella Guadagni, Raffaele Palmirotta, Gianluca Testa, Valeria Caso, Maurizio Paciaroni, Pasquale Abete, Franco Rengo, Patrizia Ferroni, Ralph L Sacco, Tatjana Rundek

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.

Original languageEnglish
Pages (from-to)595-613
Number of pages19
JournalPharmacogenomics
Volume13
Issue number5
DOIs
StatePublished - Apr 1 2012

Fingerprint

Stroke
Therapeutics
Cerebrovascular Disorders
Western World
Pharmacogenetics
Genetic Testing
Drug Discovery
Patient Selection
Genes
Cause of Death
Atherosclerosis
Genome
Phenotype
Research
Pharmaceutical Preparations

Keywords

  • atherosclerosis
  • carotid intima-media thickness
  • carotid plaque
  • genes
  • genome-wide association study
  • ischemic stroke
  • monogenic stroke
  • pharmacogenetics
  • SNPs
  • vascular risk factors

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. / Della Morte, David; Guadagni, Fiorella; Palmirotta, Raffaele; Testa, Gianluca; Caso, Valeria; Paciaroni, Maurizio; Abete, Pasquale; Rengo, Franco; Ferroni, Patrizia; Sacco, Ralph L; Rundek, Tatjana.

In: Pharmacogenomics, Vol. 13, No. 5, 01.04.2012, p. 595-613.

Research output: Contribution to journalArticle

Della Morte, D, Guadagni, F, Palmirotta, R, Testa, G, Caso, V, Paciaroni, M, Abete, P, Rengo, F, Ferroni, P, Sacco, RL & Rundek, T 2012, 'Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments', Pharmacogenomics, vol. 13, no. 5, pp. 595-613. https://doi.org/10.2217/pgs.12.14
Della Morte, David ; Guadagni, Fiorella ; Palmirotta, Raffaele ; Testa, Gianluca ; Caso, Valeria ; Paciaroni, Maurizio ; Abete, Pasquale ; Rengo, Franco ; Ferroni, Patrizia ; Sacco, Ralph L ; Rundek, Tatjana. / Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. In: Pharmacogenomics. 2012 ; Vol. 13, No. 5. pp. 595-613.
@article{87bf74efba1947f7ad8ebe10a845616a,
title = "Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments",
abstract = "Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80{\%} of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.",
keywords = "atherosclerosis, carotid intima-media thickness, carotid plaque, genes, genome-wide association study, ischemic stroke, monogenic stroke, pharmacogenetics, SNPs, vascular risk factors",
author = "{Della Morte}, David and Fiorella Guadagni and Raffaele Palmirotta and Gianluca Testa and Valeria Caso and Maurizio Paciaroni and Pasquale Abete and Franco Rengo and Patrizia Ferroni and Sacco, {Ralph L} and Tatjana Rundek",
year = "2012",
month = "4",
day = "1",
doi = "10.2217/pgs.12.14",
language = "English",
volume = "13",
pages = "595--613",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments

AU - Della Morte, David

AU - Guadagni, Fiorella

AU - Palmirotta, Raffaele

AU - Testa, Gianluca

AU - Caso, Valeria

AU - Paciaroni, Maurizio

AU - Abete, Pasquale

AU - Rengo, Franco

AU - Ferroni, Patrizia

AU - Sacco, Ralph L

AU - Rundek, Tatjana

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.

AB - Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.

KW - atherosclerosis

KW - carotid intima-media thickness

KW - carotid plaque

KW - genes

KW - genome-wide association study

KW - ischemic stroke

KW - monogenic stroke

KW - pharmacogenetics

KW - SNPs

KW - vascular risk factors

UR - http://www.scopus.com/inward/record.url?scp=84859222074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859222074&partnerID=8YFLogxK

U2 - 10.2217/pgs.12.14

DO - 10.2217/pgs.12.14

M3 - Article

C2 - 22462751

AN - SCOPUS:84859222074

VL - 13

SP - 595

EP - 613

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 5

ER -